Aytu Biopharma (AYTU) Other Non-Current Liabilities (2015 - 2026)
Aytu Biopharma (AYTU) reported Other Non-Current Liabilities of $4.77 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 81.9% from $26.33 million a year earlier and down 1.4% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends
Dating back to fiscal Q3 2015, Aytu Biopharma's Other Non-Current Liabilities record includes 46 quarters.
- Other Non-Current Liabilities has a five-year compound annual growth rate of -23.7% (FY2021 to FY2026).
- By fiscal year, Other Non-Current Liabilities came in at $26.33 million in FY2025 (+106.6%), $12.75 million in FY2024 (+82.7%), $6.98 million in FY2023 (-45.5%) and $12.8 million in FY2022 (-30.8%).
- The fiscal Q4 2026 figure ranks as the lowest quarterly Other Non-Current Liabilities since fiscal Q1 2019.
- Year over year, Other Non-Current Liabilities gained in three of the last eight quarters, with growth averaging 43.9%.
- The high point for year-over-year Other Non-Current Liabilities in five years was fiscal Q2 2026 (growth of 328.1%); the low point was fiscal Q4 2026 (a decline of 81.9%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $4.84 million (Q3 2026), $27.34 million (Q2 2026) and $20.42 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Aytu Biopharma | 23.25 Mn | -92.42 Mn | 10.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.77 Mn |
| Mar 31, 2026 | 4.84 Mn |
| Dec 31, 2025 | 27.34 Mn |
| Sep 30, 2025 | 20.42 Mn |
| Jun 30, 2025 | 26.33 Mn |
| Mar 31, 2025 | 4.94 Mn |
| Dec 31, 2024 | 6.39 Mn |
| Sep 30, 2024 | 9.40 Mn |
| Jun 30, 2024 | 12.75 Mn |
| Mar 31, 2024 | 8.61 Mn |
| Dec 31, 2023 | 12.89 Mn |
| Sep 30, 2023 | 12.31 Mn |
| Jun 30, 2023 | 6.98 Mn |
| Mar 31, 2023 | 7.92 Mn |
| Dec 31, 2022 | 9.78 Mn |
| Sep 30, 2022 | 9.33 Mn |
| Jun 30, 2022 | 12.80 Mn |
| Mar 31, 2022 | 5.58 Mn |
| Dec 31, 2021 | 8.30 Mn |
| Sep 30, 2021 | 8.17 Mn |
API Access
Aytu Biopharma Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();